Our cardiovascular studies remain a primary focus and account for more than 40% of our study profile. This area continues to be supported by the extensive experience gained throughout our large cardiovascular endpoint trials.

Areas of expertise include

  • Angina
  • Atrial Fibrillation
  • C-Reactive protein
  • Cardiac events & endpoint studies
  • Coronary artery disease
  • Dyslipidemia
  • Heart failure
  • Hypercholesterolaemia
  • Hypertension
  • Lipids & Cholesterol

Experienced in over

770

cardiology studies

Providing care to over

31K

cardiology patients

Synexus community patients

16%

have cardiovascular diseases